Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011674 · ClinicalTrials.gov registry record
Early Exposure to Lead and Adolescent Development
A clinical trial of Lead Poisoning, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT00011674: Completed study of Lead Poisoning, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00011674 is a study of Lead Poisoning that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00011674, a study of Lead Poisoning, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective cohort study examines the role of prenatal and early postnatal lead exposure on the neuropsychological status and social adjustment of adolescents enrolled in the Cincinnati Lead Study. We are examining the relationship between moderate exposure to lead and neuropsychological deficits, difficulties in peer relationships, personality disturbances and juvenile delinquency. This birth cohort of approximately 300 subjects has been followed since 1980 with regularly scheduled assessments of blood lead concentrations, health history, social and hereditary factors, and neurobehavioral development.
Conditions Studied
Study Locations (1)
Ohio
- Findlay Street Clinic - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 1997-05 |
| Est. Completion | 2001-05 |
What the finished NCT00011674 record still lists
NCT00011674 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Lead Poisoning appearing as the primary indexed condition, and to 0 interventions.
NCT00011674 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00011674 about?
NCT00011674 is a clinical study titled "Early Exposure to Lead and Adolescent Development". This prospective cohort study examines the role of prenatal and early postnatal lead exposure on the neuropsychological status and social adjustment of adolescents enrolled in the Cincinnati Lead Study. We are examining the relationship between moderate exposure to lead and neuropsychological defici...
What is the current status of trial NCT00011674?
This trial is currently completed. The enrollment target is 300 participants. The study started on 1997-05. Estimated completion is 2001-05.
What conditions does trial NCT00011674 study?
This clinical trial studies the following conditions: Lead Poisoning.
Who is sponsoring clinical trial NCT00011674?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00011674 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lead Poisoning
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia